| abstract |
Compounds of formula (I) wherein the meaning of each substituent is given in the description. Described is a process for the preparation of this derivative, a pharmaceutical composition comprising at least one compound of formula (I) and / or a physiologically acceptable salt thereof. Because of the antiarrhythmic properties of these compounds and their ability to act as inhibitors of cellular antiporter Na + / H +, they are used in the manufacture of medicaments for the treatment of arrhythmias, angina pectoris, infarction and for the preventive treatment of these indications. |